Patents/Assignees

Forty Seven, Inc.

7 patents in portfolio

US12091458utility2024
Humanized Antibodies Against C-kit
0 cites
US12060423utility2024
Humanized, Mouse or Chimeric Anti-cd47 Monoclonal Antibodies
0 cites
US11891450utility2024
Anti-cd47 Agent-based Treatment of Cd20-positive Cancer
0 cites
US11802153utility2023
Anti-cd47 Agent-based Ovarian Cancer Therapy
0 cites
US11795223utility2023
Combination Therapies for Treating Myelodysplastic Syndromes and Acute Myeloid Leukemia
0 cites
US11753480utility2023
Anti-sirp-alpha Antibodies and Related Methods
0 cites
US11643461utility2023
Humanized, Mouse or Chimeric Anti-cd47 Monoclonal Antibodies
0 cites